https://www.selleckchem.com/products/cp-91149.html
The median time to progression, progression-free survival, and overall-survival was 2.36 years (95% CI 1.54-8.7, 1.96 years (95% CI 1.43-3.74), and 3.51 years (95% CI 2.33-10.02), respectively. ITAC is an uncommon malignancy that grows silently, which contributes to delayed diagnosis, advanced stage and low survival rates. In our cohort, we observed a high prevalence of cork occupational exposure. This finding may lead to the implementation of protection measures and suggest a potential link to be further studied. ITAC is an uncommon